SCHEMBL25978642

SCHEMBL25978642

c1ccc(-c2ccc(N(c3ccccc3)c3cccc4oc5cc(-c6nc7ccccc7nc6-c6ccccc6)ccc5c34)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.40
ALDH1A1 P00352 6/20 0.37
LMNA P02545 3/20 0.37
THRB P10828 1/20 0.37
KDM4E B2RXH2 5/20 0.37
TDP1 Q9NUW8 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
MEN1 O00255 1/20 0.37
NPSR1 Q6W5P4 2/20 0.35
HPGD P15428 1/20 0.34
AKT1 P31749 1/20 0.33
AKT2 P31751 1/20 0.33
PDE10A Q9Y233 1/20 0.33
ATM Q13315 1/20 0.33
TLR9 Q9NR96 1/20 0.33
HTT P42858 2/20 0.32
RXFP1 Q9HBX9 1/20 0.32
PKM P14618 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26778981 0.88 MEN1 (0.43) ALDH1A1LMNAKDM4EKMT2AMEN1
SCHEMBL26778969 0.88 MEN1 (0.43) ALDH1A1LMNAKDM4EKMT2AMEN1
SCHEMBL26778986 0.87 MEN1 (0.43) L3MBTL1ALDH1A1LMNAKDM4ETDP1
SCHEMBL25978535 0.87 MEN1 (0.43) L3MBTL1ALDH1A1LMNAKDM4ETDP1
SCHEMBL25978567 0.86 MEN1 (0.39) ALDH1A1LMNAKDM4ETDP1KMT2A
SCHEMBL26778644 0.86 KMT2A (0.33) L3MBTL1ALDH1A1LMNAKDM4EKMT2A
SCHEMBL25978370 0.86 KMT2A (0.33) L3MBTL1ALDH1A1LMNAKDM4EKMT2A
SCHEMBL25978390 0.86 KMT2A (0.33) L3MBTL1ALDH1A1LMNAKDM4EKMT2A
SCHEMBL26778684 0.86 KMT2A (0.33) L3MBTL1ALDH1A1LMNAKDM4EKMT2A
SCHEMBL29298082 0.85 NPC1 (0.44) ALDH1A1LMNAKDM4ETDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 L3MBTL1 1367/4885ALDH1A1 9/4885LMNA 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.